Most studies were focused on the assessment of unhealthy
lifestyle, metabolic abnormalities and cardiovascular risk in chronic
patients with schizophrenia. In the majority of the studies, the
results were compared with data from the general population,
instead of data from a matched control group. Four studies focused
on first-episode psychosis patients papers reported
a detailed medication history. Results from papers focused on fi rst-episode patients were usually concordant with those from studies
involving chronic patients. A summary of the details and fi ndings of
the studies is shown in Table 2